RxDoctor Payments Data

Douglas Holmes, MD

Otolaryngology · Mobile, ALNPI 1861460156

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,882 of the $3,262 with a category attached, or 88.4%. It is spread thinly across 14 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations.

$3,262in general payments, 2019–2025

Across 63 payments — averaging $51.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$618
  • Acclarent, Inc$553
  • Cochlear Americas$446
  • Inspire Medical Systems, Inc.$343
  • Optinose US, Inc.$253
  • Medtronic$228
  • plus $821 from 8 others

What the payments were for

  • Consulting fees$752%
  • Travel & lodging$3049%
  • Food & beverage$2,88288%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,262 in reported general payments places this provider in the 70th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$2,461
Medicare patients
15
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide13$329

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →